Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters

09 Nov 2024

Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Organovo Holdings Inc ONVO.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -46 cents. The lone analyst forecast for the quarter was for a loss of 26 cents per share.
Revenue was $30.00 thousand; analysts expected $41.00 thousand.
Organovo Holdings Inc's reported EPS for the quarter was a loss of 14 cents.
Organovo Holdings Inc shares had fallen by 15.5% this quarter and lost 61.3% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

Wall Street's median 12-month price target for Organovo Holdings Inc is $6.10

This summary was machine generated from LSEG data November 8 at 09:45 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING	ESTIMATE	ACTUAL	BEAT, MET, MISSED
Sep. 30 2024	-0.26	-0.14	Beat
Jun. 30 2024	-0.33	-0.23	Beat
Mar. 31 2024	-0.42	-0.29	Beat
Dec. 31 2023	-0.44	-0.40	Beat

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/news/2482555451"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2482555451\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2482555451?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-09 05:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482555451","market":"us","top_or_hot":-1,"title":"Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings Summary","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings Summary</title></head><body><ul><li><p>Organovo Holdings Inc <span>ONVO.OQ</span> reported a quarterly adjusted loss of 14 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -46 cents.  The lone analyst forecast for the quarter was for a loss of 26 cents per share. </p></li><li><p>Revenue was $30.00 thousand; analysts expected $41.00 thousand. </p></li><li><p>Organovo Holdings Inc's reported EPS for the quarter was a loss of 14 cents.</p></li><li><p>Organovo Holdings Inc shares had fallen by 15.5% this quarter and lost 61.3% so far this year.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p></li></ul><p>RECOMMENDATIONS</p><ul><li></li><li><p>Wall Street's median 12-month price target for Organovo Holdings Inc is $6.10 </p></li></ul><p>This summary was machine generated from LSEG data November 8 at 09:45 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>-0.26</p></td><td><p>-0.14</p></td><td><p>Beat</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>-0.33</p></td><td><p>-0.23</p></td><td><p>Beat</p></td></tr><tr><td><p>Mar. 31 2024 </p></td><td><p>-0.42</p></td><td><p>-0.29</p></td><td><p>Beat</p></td></tr><tr><td><p>Dec. 31 2023 </p></td><td><p>-0.44</p></td><td><p>-0.40</p></td><td><p>Beat</p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrganovo Holdings Inc reports results for the quarter ended September 30 - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-11-09 05:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings Summary</title></head><body><ul><li><p>Organovo Holdings Inc <span>ONVO.OQ</span> reported a quarterly adjusted loss of 14 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -46 cents.  The lone analyst forecast for the quarter was for a loss of 26 cents per share. </p></li><li><p>Revenue was $30.00 thousand; analysts expected $41.00 thousand. </p></li><li><p>Organovo Holdings Inc's reported EPS for the quarter was a loss of 14 cents.</p></li><li><p>Organovo Holdings Inc shares had fallen by 15.5% this quarter and lost 61.3% so far this year.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p></li></ul><p>RECOMMENDATIONS</p><ul><li></li><li><p>Wall Street's median 12-month price target for Organovo Holdings Inc is $6.10 </p></li></ul><p>This summary was machine generated from LSEG data November 8 at 09:45 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>-0.26</p></td><td><p>-0.14</p></td><td><p>Beat</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>-0.33</p></td><td><p>-0.23</p></td><td><p>Beat</p></td></tr><tr><td><p>Mar. 31 2024 </p></td><td><p>-0.42</p></td><td><p>-0.29</p></td><td><p>Beat</p></td></tr><tr><td><p>Dec. 31 2023 </p></td><td><p>-0.44</p></td><td><p>-0.40</p></td><td><p>Beat</p></td></tr></tbody></table></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ONVO","symbol_name":"Organovo Holdings Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF3UO:1","article_id":"2482555451","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482555451","pubTimestamp":1731102367,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings SummaryOrganovo Holdings Inc ONVO.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ended ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ONVO":"Organovo Holdings Inc."},"translate_title":"Organovo Holdings Inc报告截至9月30日的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONVO":0.9},"content_text":"Organovo Holdings Inc reports results for the quarter ended September 30 - Earnings SummaryOrganovo Holdings Inc ONVO.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -46 cents.  The lone analyst forecast for the quarter was for a loss of 26 cents per share. Revenue was $30.00 thousand; analysts expected $41.00 thousand. Organovo Holdings Inc's reported EPS for the quarter was a loss of 14 cents.Organovo Holdings Inc shares had fallen by 15.5% this quarter and lost 61.3% so far this year.FORECAST CHANGESThe mean earnings estimate of analysts was unchanged in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONSWall Street's median 12-month price target for Organovo Holdings Inc is $6.10 This summary was machine generated from LSEG data November 8 at 09:45 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)QUARTER ENDINGESTIMATE ACTUALBEAT, MET, MISSEDSep. 30 2024 -0.26-0.14BeatJun. 30 2024 -0.33-0.23BeatMar. 31 2024 -0.42-0.29BeatDec. 31 2023 -0.44-0.40Beat","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}